Pillar 03
Research
Funding the work that closes the survival gap.
Why colorectal cancer
A treatable disease, when caught in time.
Colorectal cancer kills about 50,000 Americans every year. It is highly preventable when caught early and increasingly treatable when caught late — but the survival gap between a Stage I diagnosis and a Stage IV diagnosis remains stark. Research closes that gap.
Memorial Sloan Kettering Cancer Center is one of the leading institutions in the world for colorectal cancer research and treatment, and runs one of the most efficient charity partnerships in American philanthropy through Fred's Team.
How we give
A focused channel into MSK.
The foundation supports MSK's gastrointestinal oncology research through Fred's Team — MSK's official charity partner at the TCS New York City Marathon. Cancer-research donations are directed to MSK colorectal research through that channel, with 100% of designated gifts reaching the program.
Why this channel
One of philanthropy's most efficient partnerships.
Fred's Team is among the most operationally efficient charity-running partnerships in American philanthropy. Funds raised through the program flow directly to specific MSK research programs designated at the time of giving. There is no intermediary fundraising layer between the donor and the researcher.
Fund the next breakthrough.
Help close the survival gap.
100% of designated cancer-research gifts flow to Memorial Sloan Kettering through Fred's Team. The foundation takes no overhead on designated cancer-research donations.
Donate to research